Iclusig (ponatinib) — Medica
Gastrointestinal Stromal Tumor (GIST)
Preferred products
- imatinib
- Ayvakit (avapritinib)
- sunitinib
- Stivarga (regorafenib)
- Qinlock (ripretinib)
- dasatinib
Initial criteria
- Patient age ≥ 18 years
- Patient has tried each of the following: one of imatinib or Ayvakit (avapritinib tablets); one of sunitinib or dasatinib; Stivarga (regorafenib tablets); and Qinlock (ripretinib tablets)
Approval duration
1 year